
Sign up to save your podcasts
Or


Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review results of ASPECT-NP (Ceftolozane-tazobactam versus meropenem in patients with ventilated nosocomial pneumonia), CAMERA-2 (Combination therapy for methicillin-resistant Staphylococcus aureus bacteraemia), and Exebacase for patients with methicillin-resistant Staphylococcus aureus bacteraemia (Phase 2).
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
By Society of Infectious Diseases Pharmacists4.9
169169 ratings
Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review results of ASPECT-NP (Ceftolozane-tazobactam versus meropenem in patients with ventilated nosocomial pneumonia), CAMERA-2 (Combination therapy for methicillin-resistant Staphylococcus aureus bacteraemia), and Exebacase for patients with methicillin-resistant Staphylococcus aureus bacteraemia (Phase 2).
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About

321 Listeners

2,053 Listeners

504 Listeners

130 Listeners

3,374 Listeners

1,150 Listeners

518 Listeners

260 Listeners

437 Listeners

188 Listeners

29 Listeners

91 Listeners

270 Listeners

3 Listeners

10 Listeners